TG Therapeutics Recaps Schedule of Data Presentations at the Upcoming 62nd American Society of Hematology Annual Meeting and Exposition

NEXT STORY
Expanding Immunoscore® clinical utility on 3000+ stage III colon cancer patients
PREV STORY
Veterinary Diagnostics Market to Reach $5.38 Billion by 2027, Growing at a CAGR of 8.7% From 2020 With COVID-19 Impact – Meticulous Research® Analysis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Hopewell Promotes Assessments and Tours During May Mental Health Awareness Month

MESOPOTAMIA, Ohio, May 11, 2016 (GLOBE NEWSWIRE) -- Hopewell therapeutic farm for people with ...

author_avatar
NASDAQ Market News

Fate Therapeutics Highlights Positive Durability of Response Data from FT516 Phase 1 Study for B-cell Lymphoma and Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to FT516 for Relapsed / Refractory DLBCL

author_avatar
NASDAQ Market News

Syndax Appoints Lisa M. Coussens, Ph.D., to Scientific Advisory Board

WALTHAM, Mass., Jan. 31, 2017 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. ("Syndax," the “Company” ...

author_avatar
NASDAQ Market News